Calls Now Open
2024 ADDF-Harrington + 2025 Harrington Scholar-Innovator Programs
This program is currently closed. Join our emailing list to become a part of our community and receive periodic communications about grant funding opportunities, as well as news and updates.
Sponsored by Takeda Pharmaceutical Company Limited, the Harrington Rare Disease Scholar Award is a US-based program that provides award recipients with a substantial grant, drug development expertise, project management support, access to Takeda’s R&D experts, and more. The award includes:
The Harrington Discovery Institute and its Therapeutics Development Center work closely with the award recipient and their affiliated institution to maximize the clinical and commercial potential of the selected project.
Late submissions will not be accepted for any reason, other than issues with the Harrington Discovery Institute’s submission system. Proposals received after the deadline will not be reviewed.
The Harrington Rare Disease Scholar award selection committee seeks breakthrough discovery defined by innovation, creativity and potential for clinical impact including: